|
|
|
|
 |
 |
Spanning Disciplines, Advancing Knowledge Promoting Awareness, Progress, and Applications of the Human Genome Project |
Sponsored by the U.S. Department of Energy Human Genome Program
Human
Genome News Archive Edition |
Human Genome News, October-December 1996; 8:(2)
An overview of challenges facing gene therapy is presented in a special feature of the September 10, 1996, issue of Human Gene Therapy (7, 1781-90). "Gene Therapy in the United States: A Five-Year Status Report" concludes that it clearly is too early to assess the therapeutic efficacy of gene therapy or even to predict its promise. Although the public is excited about novel medical cures and some measure of success has been achieved in certain technical aspects of gene transfer, the report says that gene therapy is still at an early stage. Nearly all the gene-therapy studies consist of Phase I trials, with the goal of establishing the procedure's safety rather than its effectiveness. [Article reprints: Brian R. Smith; Yale University School of Medicine; 333 Cedar Street, P.O. Box 208035; New Haven, CT 06520-8035]
Return to the Table of Contents
The electronic form of the newsletter may be cited in the following style:
Human Genome Program, U.S. Department of Energy, Human Genome News (v8n2).
Last modified: Wednesday, October 29, 2003
Home * Contacts * Disclaimer
Document Use and Credits
Publications and webpages on this site were created by the U.S. Department of Energy Genome Program's Biological and Environmental Research Information System (BERIS). Permission to use these documents is not needed, but please credit the U.S. Department of Energy Genome Programs and provide the website http://genomics.energy.gov. All other materials were provided by third parties and not created by the U.S. Department of Energy. You must contact the person listed in the citation before using those documents.
Base URL: www.ornl.gov/hgmis
Site sponsored by the U.S. Department of Energy
Office of Science, Office
of Biological and Environmental Research, Human
Genome Program
